Mark C. Schneyer
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 7SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 5,84967,828 held (−8%) | $29.00 | $170K | -31.8% |
| Aug 7SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 5,00077,120 held (−6%) | $29.00 | $145K | -31.8% |
| Aug 7SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 9,29267,828 held (−12%) | $29.34 | $273K | -32.6% |
| May 5SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 3,50666,145 held (−5%) | $21.79 | $76K | -9.2% |
| Apr 7SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 2,70962,836 held (−4%) | $22.20 | $60K | -10.9% |
| Mar 26SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 4,17757,299 held (−7%) | $21.47 | $90K | -7.9% |
| Mar 26SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 3,17160,306 held (−5%) | $21.65 | $69K | -8.6% |
| Mar 26SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 3760,269 held (−0%) | $21.72 | $804 | -8.9% |
| Nov 19SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 10,26253,338 held (−16%) | $23.69 | $243K | -16.5% |
- Sell
CFO Mark C. Schneyer sold $170K of ACAD at $29.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mark C. Schneyer sold $145K of ACAD at $29.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mark C. Schneyer sold $273K of ACAD at $29.34 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mark C. Schneyer sold $76K of ACAD at $21.79 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mark C. Schneyer sold $60K of ACAD at $22.20 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mark C. Schneyer sold $90K of ACAD at $21.47 — pre-scheduled 10b5-1 plan sale.